Videos

Ask the expert: The Diagnostic and Prognostic capabilities of Plasma Biomarkers in Alzheimer's Disease - What Does It Mean To The AD Field?

Mar 21 2022

My conversation at the ADPD 2022-Barcelona conference

 

Philip Scheltens, MD, PhD Professor of Neurology, Amsterdam University Medical Center &  Head of Dementia Fund (EQT Life Science)